What is it about?
Glutamine is the most abundant amino acid in the body and fuels immune cells, and its levels change during severe infection. We measured glutamine and related amino acids at admission in 469 patients with sepsis treated in the internal medicine department of the Trieste University Hospital, and grouped them by low, intermediate and high glutamine levels. Surprisingly, it was high glutamine - found in 7% of patients - that signalled trouble: these patients had lower body temperature, fewer white cells and lymphocytes, less inflammation (lower C-reactive protein), signs of reduced glutathione, an important antioxidant, and other metabolic disturbances. Death rates increased step by step from low to high glutamine groups, both at 30 days and at 6 months.
Featured Image
Photo by Online Marketing on Unsplash
Why is it important?
Glutamine supplementation has been widely tested in critically ill patients with disappointing results. Our findings suggest that in sepsis, elevated glutamine may reflect immune exhaustion and metabolic failure rather than a deficiency, and that it could serve as a marker to identify high-risk patients. They invite caution with indiscriminate supplementation and further research on metabolism-guided care.
Perspectives
This study turns a common assumption upside down: in some septic patients, the problem is not too little glutamine but too much. Working with the Clinica Medica in Trieste on the metabolic side of sepsis has been very instructive for an infectious diseases physician used to thinking mainly about microbes and antibiotics.
Professor Stefano Di Bella
Universita degli Studi di Trieste
Read the Original
This page is a summary of: Low, Intermediate, and High Glutamine Levels Are Progressively Associated with Increased Lymphopenia, a Diminished Inflammatory Response, and Higher Mortality in Internal Medicine Patients with Sepsis, Journal of Clinical Medicine, May 2025, MDPI AG,
DOI: 10.3390/jcm14103313.
You can read the full text:
Contributors
The following have contributed to this page







